|
1
|
Hall SF, Groome PA, Irish J and O'Sullivan
B: The natural history of patients with squamous cell carcinoma of
the hypopharynx. Laryngoscope. 118:1362–1371. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wycliffe ND, Grover RS, Kim PD and
Simental A Jr: Hypopharyngeal cancer. Top Magn Reson Imaging.
18:243–258. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Pitcher JA, Freedman NJ and Lefkowitz RJ:
G protein-coupled receptor kinases. Annu Rev Biochem. 67:653–692.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Premont RT and Gainetdinov RR:
Physiological roles of G protein-coupled receptor kinases and
arrestins. Annu Rev Physiol. 69:511–534. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Métayé T, Gibelin H, Perdrisot R and
Kraimps JL: Pathophysiological roles of G-protein-coupled receptor
kinases. Cell Signal. 17:917–928. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Dorn GW II: GRK mythology: G-protein
receptor kinases in cardiovascular disease. J Mol Med Berl.
87:455–463. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ahmed MR, Berthet A, Bychkov E, Porras G,
Li Q, Bioulac BH, Carl YT, Bloch B, Kook S, Aubert I, et al:
Lentiviral overexpression of GRK6 alleviates L-dopa-induced
dyskinesia in experimental Parkinson's disease. Sci Transl Med.
2:28ra282010.PubMed/NCBI
|
|
8
|
Eijkelkamp N, Heijnen CJ, Lucas A, Premont
RT, Elsenbruch S, Schedlowski M and Kavelaars A: G protein-coupled
receptor kinase 6 controls chronicity and severity of dextran
sodium sulphate-induced colitis in mice. Gut. 56:847–854. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Murga C and Mayor F Jr: GRK6, a gatekeeper
of visceral hyperalgesia. Brain Behav Immun. 23:16–17. 2009.
View Article : Google Scholar
|
|
10
|
Tiedemann RE, Zhu YX, Schmidt J, Yin H,
Shi CX, Que Q, Basu G, Azorsa D, Perkins LM, Braggio E, et al:
Kinome-wide RNAi studies in human multiple myeloma identify
vulnerable kinase targets, including a lymphoid-restricted kinase,
GRK6. Blood. 115:1594–1604. 2010. View Article : Google Scholar :
|
|
11
|
Sutton N, Smith N, Thomas AJ, Raghuwanshi
SK and Richardson RM: Abstract 2821: GRK6 deficiency promotes tumor
aggressiveness and metastasis in a murine model of human lung
cancer. Cancer Res. 73(Suppl 8): 2821. 2013. View Article : Google Scholar
|
|
12
|
Yuan L, Zhang H, Liu J, Rubin JB, Cho YJ,
Shu HK, Schniederjan M and MacDonald TJ: Growth factor
receptor-Src-mediated suppression of GRK6 dysregulates CXCR4
signaling and promotes medulloblastoma migration. Mol Cancer.
12:182013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hara S, Arawaka S, Sato H, Machiya Y, Cui
C, Sasaki A, Koyama S and Kato T: Serine 129 phosphorylation of
membrane-associated alpha-synuclein modulates dopamine transporter
function in a G protein-coupled receptor kinase-dependent manner.
Mol Biol Cell. 24:1649–1660. 2013. View Article : Google Scholar :
|
|
14
|
Benovic JL and Gomez J: Molecular cloning
and expression of GRK6. A new member of the G protein-coupled
receptor kinase family. J Biol Chem. 268:19521–19527.
1993.PubMed/NCBI
|
|
15
|
Zhou Y, Huang X, Wu H, Xu Y, Tao T, Xu G,
Cheng C and Cao S: Decreased expression and role of GRK6 in spinal
cord of rats after chronic constriction injury. Neurochem Res.
38:2168–2179. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Willets JM, Challiss RA and Nahorski SR:
Endogenous G protein-coupled receptor kinase 6 regulates M3
muscarinic acetylcholine receptor phosphorylation and
desensitization in human SH-SY5Y neuroblastoma cells. J Biol Chem.
277:15523–15529. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chen Y, Lu B, Yang Q, Fearns C, Yates JR
III and Lee JD: Combined integrin phosphoproteomic analyses and
small interfering RNA-based functional screening identify key
regulators for cancer cell adhesion and migration. Cancer Res.
69:3713–3720. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Teicher BA and Fricker SP: CXCL12
(SDF-1)/CXCR4 pathway in cancer. Clin Cancer Res. 16:2927–2931.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
McCormick PJ, Segarra M, Gasperini P,
Gulino AV and Tosato G: Impaired recruitment of Grk6 and
beta-Arrestin 2 causes delayed internalization and desensitization
of a WHIM syndrome-associated CXCR4 mutant receptor. PLoS One.
4:e81022009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Vroon A, Heijnen CJ, Raatgever R, Touw IP,
Ploemacher RE, Premont RT and Kavelaars A: GRK6 deficiency is
associated with enhanced CXCR4-mediated neutrophil chemotaxis in
vitro and impaired responsiveness to G-CSF in vivo. J Leukoc Biol.
75:698–704. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Raghuwanshi SK: GRK6 deficiency promotes
angiogenesis, tumor progression and metastasis. J Immunol.
190:8962013. View Article : Google Scholar
|
|
22
|
Premont RT, Claing A, Vitale N, Freeman
JL, Pitcher JA, Patton WA, Moss J, Vaughan M and Lefkowitz RJ:
beta2-Adrenergic receptor regulation by GIT1, a G protein-coupled
receptor kinase-associated ADP ribosylation factor
GTPase-activating protein. Proc Natl Acad Sci USA. 95:14082–14087.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ribas C, Penela P, Murga C, Salcedo A,
García-Hoz C, Jurado-Pueyo M, Aymerich I and Mayor F Jr: The G
protein-coupled receptor kinase (GRK) interactome: Role of GRKs in
GPCR regulation and signaling. Biochim Biophys Acta. 1768:913–922.
2007. View Article : Google Scholar
|
|
24
|
Pronin AN, Satpaev DK, Slepak VZ and
Benovic JL: Regulation of G protein-coupled receptor kinases by
calmodulin and localization of the calmodulin binding domain. J
Biol Chem. 272:18273–18280. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Razin A and Riggs AD: DNA methylation and
gene function. Science. 210:604–610. 1980. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wei DM, Liu DY, Lei DP, Jin T, Wang J and
Pan XL: Aberrant methylation and expression of DAPk1 in human
hypopharyngeal squamous cell carcinoma. Acta Otolaryngol.
135:70–78. 2015. View Article : Google Scholar
|
|
27
|
Christman JK: 5-Azacytidine and
5-aza-2′-deoxycytidine as inhibitors of DNA methylation:
Mechanistic studies and their implications for cancer therapy.
Oncogene. 21:5483–5495. 2002. View Article : Google Scholar : PubMed/NCBI
|
